Key facts
- This page summarizes Ann D. Rhoads's Form 4 filing for GLOBUS MEDICAL INC (GMED).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 08 Jun 2026, 17:14.
Ann D. Rhoads - 04 Jun 2026 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)
- Reporting relationship
- Director
- Issuer ticker
- GMED
- Reported as of
- 04 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 Jun 2026, 17:14:27 UTC
- Prior SEC filing
- 02 Jun 2026
- Next SEC filing
- 29 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kelly G. Huller, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ann D. Rhoads filed Form 4 for GLOBUS MEDICAL INC (GMED) on 08 Jun 2026.
Change
- Previous filing in this sequence was filed on 02 Jun 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001250252
Primary reporting owner
RHOADS ANN D
- Relationship
- Director
- Address
- VALLEY FORGE BUSINESS CENTER, 2560 GENERAL ARMISTEAD AVENUE, AUDUBON
- Signature
- /s/ Kelly G. Huller, Attorney-in-Fact
- Signature date
- 08 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GMED
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +25,000
- Change %
- +163%
- Price
- $26.27*
- Shares after
- 40,384
- Date
- 04 Jun 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GMED
transaction
Derivative
Stock Option (Right to Buy Class A Common Stock)
Options Exercise
- Transaction value
- Shares
- -25,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 04 Jun 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 25,000
- Exercise price
- $26.27
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
These options were granted on January 30, 2017 and are fully vested.